Evidence map›Paper›PMID 26346709›Full record

ArticleClinical genetics2016

A Mayan founder mutation is a common cause of deafness in Guatemala.

C Carranza, I Menendez, M Herrera, P Castellanos, C Amado, F Maldonado, L Rosales, N Escobar, M Guerra, D Alvarez and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. TheGenes · 2023
    Article
  4. Review
  5. Biology · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

C CarranzaInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
I MenendezDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
M HerreraInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
P CastellanosCenter for Hearing and Phonetic Training, CEDAF, Guatemala City, Guatemala.
C AmadoInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
F MaldonadoTherapeutic Center for Hearing and Language, CEAL, Guatemala City, Guatemala.
L RosalesInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
N EscobarInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
M GuerraInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
D AlvarezInstitute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala.
J FosterDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
S GuoDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
S H BlantonDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
G BademciDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
M TekinDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Universidad Francisco Marroquín · GTUniversity of Miami · USDr. John T. Macdonald Foundation · USCenter for the Study of Equity and Governance in Health Systems · GTCentro Universitario Ciudad Vieja · GT

Funding

A Collaborative Search for New Genes for Non-Syndromic DeafnessR01DC009645 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MUSTAFA TEKIN · 2010 to 2026
$11.8M
NIDCD NIH HHS R01 DC009645
6 · The paper itself

Abstract

Over 5% of the world's population has varying degrees of hearing loss. Mutations in GJB2 are the most common cause of autosomal recessive non-syndromic hearing loss (ARNHL) in many populations. The frequency and type of mutations are influenced by ethnicity. Guatemala is a multi-ethnic country with four major populations: Maya, Ladino, Xinca, and Garifuna. To determine the mutation profile of GJB2 in a ARNHL population from Guatemala, we sequenced both exons of GJB2 in 133 unrelated families. A total of six pathogenic variants were detected. The most frequent pathogenic variant is c.131G>A (p.Trp44*) detected in 21 of 266 alleles. We show that c.131G>A is associated with a conserved haplotype in Guatemala suggesting a single founder. The majority of Mayan population lives in the west region of the country from where all c.131G>A carriers originated. Further analysis of genome-wide variation of individuals carrying the c.131G>A mutation compared with those of Native American, European, and African populations shows a close match with the Mayan population.

Indexed as

connexin 26founder effectGJB2hearing lossMayamutations

Identifiers

PMID26346709
PMCPMC5484753
OpenAlexW2118756555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.